Allergic Clinical Trials

2 recruitingLast updated: May 4, 2026

Allergic Trials at a Glance

79 actively recruiting trials for allergic are listed on ClinicalTrialsFinder across 6 cities in 24 countries. The largest study group is Not Applicable with 24 trials, with the heaviest enrollment activity in Wuhan, Beijing, and Jinan. Lead sponsors running allergic studies include Inmunotek S.L., Qianfoshan Hospital, and The First Affiliated Hospital with Nanjing Medical University.

Browse allergic trials by phase

Treatments under study

About Allergic Clinical Trials

Looking for clinical trials for Allergic? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Allergic trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Allergic clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 79 trials

Recruiting

The Role of the Nasal Allergen Provocation Test in Starting and Monitoring Allergen Immunotherapy

Seasonal Allergic RhinitisPerennial Allergic RhinitisLocal Allergic Rhinitis
Universitaire Ziekenhuizen KU Leuven200 enrolled2 locationsNCT04544774
Recruiting
Not Applicable

THREAT: Testing Harms Related to Exposure to Allergenic and Epithelial Toxins

AllergicInflammatory
National Institute of Allergy and Infectious Diseases (NIAID)120 enrolled1 locationNCT07271381
Recruiting
Phase 4

Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy

Allergic Reactions
ARS Pharmaceuticals, Inc.600 enrolled6 locationsNCT06834165
Recruiting
Phase 3

A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)

Perennial Allergic Rhinitis (PAR)
Eli Lilly and Company450 enrolled77 locationsNCT06339008
Recruiting
Phase 3

A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma (HAS3)

Allergic Asthma
Bridgette Jones300 enrolled1 locationNCT04699604
Recruiting

A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA

Allergic Bronchopulmonary AspergillosisEfficacy and SafetyABPA+3 more
Qianfoshan Hospital50 enrolled1 locationNCT07362693
Recruiting

Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary Aspergillosis

Allergic Bronchopulmonary AspergillosisSevere AsthmaABPA
Qianfoshan Hospital20 enrolled2 locationsNCT07530770
Recruiting
Phase 2

Phase 2 Study of Lesigercept in Adult Patients With Chronic Spontaneous Urticaria Who Are Inadequately Controlled by H1-Antihistamines

Chronic Spontaneous Urticaria (CSU)Allergic Diseases
Yuhan Corporation150 enrolled30 locationsNCT07415551
Recruiting
Not Applicable

Oral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in CPA-ABPA Overlap Syndrome

Allergic Bronchopulmonary AspergillosisChronic Pulmonary Aspergillosis
Post Graduate Institute of Medical Education and Research, Chandigarh104 enrolled2 locationsNCT05444946
Recruiting
Phase 2

Clinical Study on TQH2722 Injection Combined With Background Therapy for Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.300 enrolled30 locationsNCT07398859
Recruiting
Not Applicable

Dietary Intervention on Atopy

Atopic DermatitisAllergic DiseasesAllergic Rhinitis+1 more
National University of Singapore110 enrolled1 locationNCT06547372
Recruiting
Not Applicable

Evaluation of a Digital Tool to Improve Aeroallergen Immunotherapy Adherence. NavigAITme Project

Allergic Rhinitis
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa880 enrolled1 locationNCT07419230
Recruiting
Not Applicable

Effect of AI(Artificial Intelligence)-Based Storytelling Video on Anxiety and Fear During Skin Prick Test in Children

AnxietyAsthma (Diagnosis)Allergic Rhinitis+1 more
Antalya Training and Research Hospital100 enrolled1 locationNCT07453615
Recruiting
Phase 1Phase 2

Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma

Allergic AsthmaAllergic Rhinitis
University of Zurich36 enrolled1 locationNCT06960382
Recruiting

The Efficacy of Specific Immunotherapy Guided by Component-Resolved Diagnosis for Dust Mite Allergens in Chinese Pediatric Patients With Rhinitis and/or Asthma

Allergic Rhinitis Due to House Dust Mite
The Children's Hospital of Zhejiang University School of Medicine1,000 enrolled1 locationNCT07452380
Recruiting
Phase 2

Dupilumab Effects Against Aeroallergen Challenge

Asthma, Allergic
The University of Texas Health Science Center at San Antonio88 enrolled2 locationsNCT05720325
Recruiting
Phase 2

5HTP Regulation Of Asthma In Children

Mild or Moderate Asthma With Allergic Sensitization
Indiana University20 enrolled1 locationNCT04160910
Recruiting
Not Applicable

Environmental Exposure to Heavy Metals, Nanoparticles, and Emergent Contaminants and Risk of Allergic Diseases

Allergic Contact DermatitisMetal Allergy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS280 enrolled2 locationsNCT06529913
Recruiting

ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar

Chronic Spontaneous Urticaria (CSU)Allergic Asthma
Celltrion HealthCare France225 enrolled1 locationNCT07425639
Recruiting

Impact of Help-Seeking Behaviors on Allergic Rhinitis and Mental Health: A Longitudinal Study

Mental Health ConditionsAllergic
QHSLab, Inc.200,000 enrolled1 locationNCT06623799